Anna Morrison

Anna Morrison

Managing Director, Private Markets

Anna kam 2020 als Managing Director zum Private-Markets Team von bfinance und ist für das Private Equity Research zuständig. Sie verfügt über umfassende Berufserfahrung in Investitionen und Verwaltung globaler Private-Equity-Programme für institutionelle Anleger, einschließlich Research und Due-Diligence-Prüfungen für verschiedene Strategien und Regionen. Bevor sie zu bfinance kam, war sie Investment Director bei IFM Investors, wo sie mehr als 19 Jahre lang aus Australien und dann aus Großbritannien arbeitete. Sie hatte mehr als 10 Positionen in Aufsichtsräten und Beiräten inne und betreute viele verschiedene Private-Equity Programme in einer Größenordnung von 180 Mio. $ bis ca. 1 Mrd. $.


Weitere Veröffentlichungen der Spezialisten:

The question of how to integrate private market investments into strategic asset allocation models represents one of the most significant and sensitive issues that allocators face today. This report...

Liquidity-friendly vehicles for illiquid asset classes are on the rise. In order to avoid potential pitfalls, however, it is crucial to interrogate asset managers’ approaches. As part of our...

bfinance’s quarterly report in February 2025: read the team’s latest insights on institutional investor activity, risk appetite, market developments and asset manager performance across all major...

The ‘Impact Private Debt’ sector has undergone a significant phase of expansion during the past two years. This report presents an overview of currently available strategies, while an illustrative...

‘Energy transition’ tailwinds should, it is often argued, boost the prices of particular commodities in the years ahead.

A new survey of more than 300 investors (Global Asset Owner Survey, November 2024) indicates that more than 40% believe ‘like-for-like’ fees for Private Equity managers have decreased in the past...

A secular macroeconomic transition has created an unenviable series of choices—and potential traps— for pension funds, insurers, endowments, foundations, family offices and other ‘asset owners’...

Private debt investors are eyeing apparently superior returns in healthcare lending, with funds’ net IRR targets suggesting a premium of more than 300bps versus conventional direct lending...